Stay updated with breaking news from Setfirst Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GlaxoSmithKline has announced that Securities & Exchange Commission has approved proposal to pay off shareholder as it prepares to leave Nigeria.
GlaxoSmithKline Consumer Nigeria Plc 1 Industrial Avenue, Ilupeju RC 8726 PMB 21218 Ikeja, Lagos Tel: +234 2711000, 3242900...
For GSK Nigeria, this development is laden with layers of complexity, driven by a mix of challenges within the company and external factors.
Renowned for products such as Panadol, Lucozade, Ribena, Macleans and Sensodyne that a lot of Nigerians have grown fond of, the British pharmaceutical giant - GlaxoSmithKline Plc (GSK) has called off its operations in Nigeria after about 52 years.
This was disclosed in a press statement issued on Thursday and filed with the Nigerian Exchange Limited